Literature Updates

Yang Yang, MD, Hong Zhang, MD, Bin Li, MD, Jinchen Shao, MD, Zhichao Liu, MD, Rong Hua, MD, Zhigang Li, MD

Read Abstract: Patterns of Recurrence After Robot-Assisted Minimally Invasive Esophagectomy in Esophageal Squamous Cell Carcinoma - Seminars in Thoracic and Cardiovascular Surgery (semthorcardiovascsurg.com) 

James Walmsley, Arun Ariyarathenam, Richard Berrisford, Lee Humphreys, Grant Sanders, Ji Chung Tham, Tim Wheatley & David S.Y. Chan

Oshikiri, Taro MD, PhD¹; Goto, Hironobu MD, PhD¹; Kato, Takashi MD¹; Hasegawa, Hiroshi MD, PhD¹; Kanaji, Shingo MD, PhD¹; Yamashita, Kimihiro MD, PhD¹; Fujino, Yasuhiro MD, PhD²; Tominaga, Masahiro MD, PhD²; Matsuda, Takeru MD, PhD³; Kakeji, Yoshihiro MD¹

^{Read abstract:}  Improvement Effect of Upper Mediastinal Lymphadenectomy during Minimally Invasive Esophagectomy on the Prognosis in Squamous Cell Carcinoma: Efficacy Index and Propensity Score-Matching Analyses

Tajima, Kohei MD1; Koyanagi, Kazuo MD, PhD, FACS1; Ozawa, Soji MD, PhD, FACS1; Kazuno, Akihito MD, PhD1; Yamamoto, Miho MD, PhD1; Shoji, Yoshiaki MD, PhD1; Yatabe, Kentaro MD, PhD1; Kanamori, Kohei MD, PhD1; Zhao, Hongbo MD, PhD1; Mori, Masaki MD, PhD, FACS1

^{Read abstract: Effective Postoperative Surveillance Protocol after Thoracoscopic Esophagectomy Focusing on Symptoms in Patients with Esophageal Cancer}

David S. Liu PhD, FRACS, Aly Fayed MBBCh, FRACS, Penelope Evans MD, Tim Bright MS, FRACS, Ahmad Aly MS, FRACS, Cuong Duong PhD, FRACS, John Spillane MBBS, FRACS, Laurence Weinberg PhD, FANZCA & David I. Watson PhD, FRACS

Read abstract: Understanding Potentially Preventable Mortality Following Oesophago-Gastric Cancer Surgery: Analysis of a National Audit of Surgical Mortality

Shujie Huang MD, Yong Tang MD, Hansheng Wu MD, Qiuling Shi MD, PhD, Jiming Tang MD, Xiaosong Ben MD, Dongkun Zhang MD, Liang Xie MD, Haiyu Zhou MD, Gang Chen MD, Sichao Wang MD, Zhen Gao MD, Zefeng Xie MD, Rixin Chen PhD & Guibin Qiao MD, PhD

Read abstract: Early and Persistent Dysphagia Relief Predicts Tumor Response in Esophageal Squamous Cell Carcinoma Patients Treated with Immunochemotherapy

Eliza R. C. Hagens MD, PhD, Nanke Cui MD, Susan van Dieren PhD, Wietse J. Eshuis MD, PhD, Wytze Laméris MD, PhD, Mark I. van Berge Henegouwen MD, PhD & Suzanne S. Gisbertz MD, PhD

Read Abstract: Preoperative Risk Stratification in Esophageal Cancer Surgery: Comparing Risk Models with the Clinical Judgment of the Surgeon

Hai-Bo Sun MD, PhD, Duo Jiang MD, Xian-Ben Liu MD, Wen-Qun Xing MD, Pei-Nan Chen MD, PhD, Shao-Kang Feng MD & Sen Yan MD

Read abstract: Patterns and Influence of Lymph Nodal Metastases After Neoadjuvant Chemotherapy and Surgery for Thoracic Esophageal Squamous Cell Carcinoma

Yuko Kitagawa, Ryu Ishihara, Hitoshi Ishikawa, Yoshinori Ito, Takashi Oyama, Tsuneo Oyama, Ken Kato, Hiroyuki Kato, Hirofumi Kawakubo, Hiroshi Kawachi, Shiko Kuribayashi, Koji Kono, Takashi Kojima, Hiroya Takeuchi, Takahiro Tsushima, Yasushi Toh, Kenji Nemoto, Eisuke Booka, Tomoki Makino, Satoru Matsuda, Hisahiro Matsubara, Masayuki Mano, Keiko Minashi, Tatsuya Miyazaki, …Masahiro Yoshida

PURPOSE: The primary objective of these guidelines was to provide general clinicians with information that would guide them to make informed choices from the available diagnosis/treatment strategies for esophageal cancer (intended only for malignant esophageal tumors of epithelial origin, and not for any other non-epithelial malignant tumors of the esophagus or metastatic malignant esophageal tumors).

These guidelines are intended as an aid for healthcare professionals other than physicians, and also for patients and their family members, to help them understand the fundamental principles of the diagnosis and treatment of esophageal cancer.

Esophageal Cancer Practice Guidelines 2022 (JES) PART 1

Esophageal Cancer Practice Guidelines 2022 (JES) Part 2